# Commission Implementing Regulation (EU) 2018/1131 of 13 August 2018 approving penflufen as an active substance for use in biocidal products of product-type 8 (Text with EEA relevance), Annex

Extent: E+W+S+N.I.

The purity indicated in this column was the minimum degree of purity of the active substance evaluated. The active substance in the product placed on the market can be of equal or different purity if it has been proven to be technically equivalent to the evaluated active substance.
Common Name
IUPAC NameIdentification Numbers
Minimum degree of purity of the active substance
Date of approval
Expiry date of approval
Product type
Specific conditions
Penflufen
IUPAC Name:
5-fluoro-1,3-dimethyl-N-{2-[(2RS)-4-methylpentan-2-yl]phenyl}-1H-pyrazole-4-carboxamide
EC No: not available
CAS No: 494793-67-8
980 g/kg (1:1 ratio (R:S) ratio of enantiomers)
1 February 2019
31 January 2029
8
The authorisations of biocidal products are subject to the following conditions:
1.. The product assessment shall pay particular attention to the exposures, the risks and the efficacy linked to any uses covered by an application for authorisation, but not addressed in the Union-level risk assessment of the active substance.
2.. In view of the risks identified for the uses assessed, the product assessment shall pay particular attention to:
(a) industrial and professional users;
(b) soil and groundwater for wood in service that will be exposed to frequent weathering.
3.. In view of the risks identified for soil, labels, and, where provided, safety data sheets of product authorised shall indicate that industrial application shall be conducted within a contained area or on impermeable hard standing with bunding, that freshly treated timber shall be stored after treatment under shelter or on impermeable hardstanding, or both, to prevent direct losses to soil or water, and that any losses from the application of the product shall be collected for reuse or disposal.
The placing on the market of treated articles is subject to the following condition:
The person responsible for the placing on the market of a treated article treated with or incorporating penflufen shall ensure that the label of that treated article provides the information listed in the second subparagraph of Article 58(3) of Regulation (EU) No 528/2012.

---
Source: https://www.legislation.gov.uk/eur/2018/1131/annex (the official version)
Page: https://openlegislation.uk/eu-regulation-2018-1131/annex
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.